Beryl Drugs has informed that a meeting of the Board of Directors of the Company will be held on January 25, 2014, to consider and approve the Unaudited Financial Results for the quarter ended on December 31, 2013 and to consider the matter regarding forfeit of partly unpaid shares of the Company from whom the amount due not received after the due notices.
The above information is a part of company’s filings submitted to BSE